YmAbs Therapeutics (YMAB)
(Delayed Data from NSDQ)
$14.71 USD
-0.13 (-0.88%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $14.68 -0.03 (-0.20%) 7:58 PM ET
1-Strong Buy of 5 1
F Value D Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *AMC5/13/24 |
---|---|
Current Quarter | -0.12 |
EPS Last Quarter | -0.02 |
Last EPS Surprise | 89.47% |
ABR | 1.78 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.43 |
Next Year | -0.20 |
EPS (TTM) | -0.49 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 22.06M | 23.71M | 96.15M | 110.88M |
# of Estimates | 3 | 3 | 3 | 2 |
High Estimate | 23.23M | 23.75M | 96.96M | 110.88M |
Low Estimate | 21.45M | 23.64M | 95.46M | 110.87M |
Year ago Sales | 20.25M | 20.75M | 84.82M | 96.15M |
Year over Year Growth Est. | 8.92% | 14.25% | 13.36% | 15.32% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.12 | -0.10 | -0.43 | -0.20 |
# of Estimates | 3 | 3 | 4 | 3 |
Most Recent Consensus | -0.11 | -0.11 | -0.46 | -0.46 |
High Estimate | -0.11 | -0.08 | -0.38 | -0.03 |
Low Estimate | -0.13 | -0.11 | -0.46 | -0.46 |
Year ago EPS | -0.15 | -0.14 | -0.49 | -0.43 |
Year over Year Growth Est. | 20.00% | 28.57% | 12.24% | 52.13% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 4 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.12 | -0.10 | -0.43 | -0.20 |
7 Days Ago | -0.12 | -0.10 | -0.43 | -0.29 |
30 Days Ago | -0.12 | -0.10 | -0.43 | -0.29 |
60 Days Ago | -0.21 | -0.23 | -0.75 | -0.64 |
90 Days Ago | -0.21 | -0.23 | -0.68 | -0.65 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.12 | -0.10 | -0.43 | -0.03 |
Zacks Consensus Estimate | -0.12 | -0.10 | -0.43 | -0.20 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 85.25% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.02 | -0.18 | -0.14 | -0.15 | NA |
Estimate | -0.19 | -0.16 | -0.24 | -0.31 | NA |
Difference | 0.17 | -0.02 | 0.10 | 0.16 | 0.10 |
Surprise | 89.47% | -12.50% | 41.67% | 51.61% | 42.56% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more